DOI QR코드

DOI QR Code

Epidemiology and Prevention of Prostate Cancer in Vietnam

  • Dong, Hoang Van (Department of Epidemiology, National Institute of Hygiene and Epidemiology) ;
  • Lee, Andy H. (School of Public Health, Curtin University) ;
  • Nga, Nguyen Hoai (Department of Network Guidelines, National Cancer Hospital) ;
  • Quang, Nguyen (Department of Urology, Viet Duc Hospital) ;
  • Chuyen, Vu Le (Department of Urology, Binh Dan Hospital) ;
  • Binns, Colin W. (School of Public Health, Curtin University)
  • Published : 2014.12.18

Abstract

Prostate cancer is the second most common cancer in men worldwide and a leading cause of mortality. Incidences continues to rise and vary substantially between populations. Although the prevalence of prostate cancer is relatively low in Vietnam, some hospital-based reports have shown an upward trend in recent years. While certain non-modifiable factors such as age, race and genetics are known to be mainly responsible, the literature has also suggested that environmental exposures can delay the onset of this disease. The present study provides a review of the epidemiology of prostate cancer in Vietnam by systematically searching several electronic databases. The results confirm an increasing trend of prostate cancer over the past decade, with age-standardised rate more than doubled from 2.2 per 100,000 men in 2000 to 4.7 per 100,000 men in 2010. However, no study has been found on modifiable risk factors, with the exception of one in vitro experiment that showed the inhibitory effect of garlic on the growth of prostate cancer cells. The lack of epidemiological information poses a difficulty to develop public health interventions to prevent this emerging malignant disease in Vietnam.

Keywords

References

  1. Anh PTH, Duc NB (2002). The Situation with Cancer Control in Vietnam. Japanese J Clin Oncol, 32, 92-7. https://doi.org/10.1093/jjco/hye127
  2. Anh PTH, Parkin DM, Hanh NT, Duc NB (1993). Cancer in the population of Hanoi, Vietnam, 1988-1990. Br J Cancer, 68, 1236-42. https://doi.org/10.1038/bjc.1993.511
  3. Ansbaugh N, Shannon J, Mori M, Farris PE, Garzotto M (2013). Agent Orange as a risk factor for high-grade prostate cancer. Cancer, 119, 2399-404. https://doi.org/10.1002/cncr.27941
  4. Askari F, Parizi MK, Jessri M, Rashidkhani B (2014). Dietary patterns in relation to prostate cancer in Iranian men: a casecontrol study. Asian Pac J Cancer Prev, 15, 4.
  5. Baade PD, Youlden DR, Krnjacki LJ (2009). International epidemiology of prostate cancer: Geographical distribution and secular trends. Mol Nutr Food Res, 53, 171-84. https://doi.org/10.1002/mnfr.200700511
  6. Brodsky ES, Shelepchikov AA, Feshin DB, et al (2009). The current level of dioxin pollution in the area of large-scale spraying of Agent Orange in Vietnam. Doklady Biological Sciences, 429, 526-30. https://doi.org/10.1134/S0012496609060131
  7. Cancer Council of Australia (2011). Prostate cancer. Retrieved from http://www.cancer.org.au/aboutcancer/cancertypes/prostatecancer.htm.
  8. Center MM, Jemal A, Lortet-Tieulent J, et al (2012). International variation in prostate cancer incidence and mortality rates. Eur Urol, 61, 1079-92. https://doi.org/10.1016/j.eururo.2012.02.054
  9. Chamie K, DeVere White RW, Lee D, Ok J, Ellison LM (2008). Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer. Cancer, 113, 2464-70. https://doi.org/10.1002/cncr.23695
  10. Chia SE, Wong KY, Cheng C, Lau W, Tan PH (2012). Sun exposure and the risk of prostate cancer in the Singapore prostate cancer study: a case-control study. Asian Pac J Cancer Prev, 13, 3179-85. https://doi.org/10.7314/APJCP.2012.13.7.3179
  11. Crawford ED (2003). Epidemiology of prostate cancer. Urology, 62, 3-12.
  12. Crawford E D, Black L, Eaddy M, Kruep EJ (2010). A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancer. Prostate Cancer Prostatic Diseases, 13, 162-7. https://doi.org/10.1038/pcan.2009.63
  13. Dao DH (1984). The truth on prostate cancer in Vietnam. Vietnam Medicine, 5, 7.
  14. Do TKH (2003). Study on epidemiological features of benign prostate hyperplasia and the role of serum PSA in diagnosis and prognosis. Doctoral dissertation, Hanoi Medical University.
  15. Doolan G, Benke G, Giles G (2014). An Update on Occupation and Prostate Cancer. Asian Pac J Cancer Prev, 15, 5. https://doi.org/10.7314/APJCP.2014.15.2.501
  16. Drouin SJ, Roupret M (2009). Epidemiology, diagnosis and prognosis of localized prostate cancer: What's new? Progres En Urologie, 19, 3-7. https://doi.org/10.1016/S1166-7087(09)73898-9
  17. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
  18. Frumkin H (2003). Agent Orange and Cancer: An Overview for Clinicians. CA: A Cancer J Clin, 53, 245-55. https://doi.org/10.3322/canjclin.53.4.245
  19. Gross M E (2013). Prostate cancer: Age is nothing but a number. Nat Rev Urol, 10, 683-4. https://doi.org/10.1038/nrurol.2013.265
  20. Hsing AW, Chokkalingam AP, Gao YT, et al (2002). Allium vegetables and risk of prostate cancer: a population-based study. J Nat Cancer Inst, 94, 1648-51. https://doi.org/10.1093/jnci/94.21.1648
  21. International Agency for Research on Cancer (2010). Prostate cancer incidence and mortality worldwide in 2008.
  22. JainMG, Hislop GT, Howe GR, Burch JD, Ghadirian P (1998). Alcohol and other beverage use and prostate cancer risk among Canadian men. Int J Cancer, 78, 707-11. https://doi.org/10.1002/(SICI)1097-0215(19981209)78:6<707::AID-IJC7>3.0.CO;2-2
  23. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA: A Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  24. Jian L, Lee AH, Binns CW (2007). Tea and lycopene protect against prostate cancer. Asia Pac J Clin Nutr, 16, 453-7.
  25. Key T, Silcocks P, Davey G, Appleby P, Bishop D (1997). A case-control study of diet and prostate cancer. Br J Cancer, 76, 678-87. https://doi.org/10.1038/bjc.1997.445
  26. Lalitha K, Suman G, Pruthvish S, Mathew A, Murthy NS (2012). Estimation of Time Trends of Incidence of Prostate Cancer - an Indian Scenario. Asian Pac J Cancer Prev, 13, 5.
  27. Le GM, Gomez SL, Clarke CA, Glaser SL, West DW (2002). Cancer incidence patterns among Vietnamese in the United States and Ha Noi, Vietnam. Int J Cancer, 102, 412-7. https://doi.org/10.1002/ijc.10725
  28. Lee AH, Fraser ML, Binns CW (2009). Tea, coffee and prostate cancer. Mol Nutr Food Res, 53, 256-65. https://doi.org/10.1002/mnfr.200800218
  29. Long XJ, Lin S, Sun YN, Zheng ZF (2012). Diabetes mellitus and prostate cancer risk in Asian countries: a meta-analysis. Asian Pac J Cancer Prev, 13, 4097-100. https://doi.org/10.7314/APJCP.2012.13.8.4097
  30. Marshall JR (2012). Diet and prostate cancer prevention. World J Urol, 30, 157-65. https://doi.org/10.1007/s00345-011-0810-0
  31. Martin R, Vatten L, Gunnell D, Romundstad P (2010). Blood pressure and risk of prostate cancer: cohort Norway (CONOR). Cancer Causes and Control, 21, 463-72. https://doi.org/10.1007/s10552-009-9477-x
  32. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol, 62, 1006-12. https://doi.org/10.1016/j.jclinepi.2009.06.005
  33. National Cancer Institute. (2012). Prostate cancer Screening. Retrieved from http://www.cancer.gov/cancertopics/pdq/screening/prostate.
  34. Nguyen BD (2010). Cancer statistics from six cancer registry regions between 2004 and 2008. Oncology Magazine of Vietnam, 1, 73-80.
  35. Nguyen BD (2010). Perodical report on the results of national project on cancer prevention, 2008-2010. Oncology Magazine of Vietnam, 1, 6.
  36. Nguyen TL (2011). Aqueous extraction of Lyson Garlic inhibited human prostate carcinoma cell PC-3 in vitro. Vietnam Journal of Military Pharmaco-medicine. Hanoi, Medical Military University, 36, 8.
  37. NHMRC (1998). A guide to the development, implementation and evaluation of clinical practice guidelines.www.nhmrc. gov.au/guidelines/publications.
  38. Phung DT, Connell D, Miller G, et al (2013). Needs assessment for reducing pesticide risk: a case study with farmers in Vietnam. J Agromedicine, 18, 293-303. https://doi.org/10.1080/1059924X.2013.826605
  39. Quoc NM, Hung NC, Parkin DM (1998). Cancer incidence in Ho Chi Minh City, Viet Nam, 1995-1996. Int J Cancer, 76, 472-9. https://doi.org/10.1002/(SICI)1097-0215(19980518)76:4<472::AID-IJC5>3.0.CO;2-O
  40. Shaw JE, Sicree RA, Zimmet PZ (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice, 87, 4-14. https://doi.org/10.1016/j.diabres.2009.10.007
  41. Sonoda T, Nagata Y, Mori M, et al (2004). A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet. Cancer Science, 95, 238-42. https://doi.org/10.1111/j.1349-7006.2004.tb02209.x
  42. Sugiyama Y, Masumori N, Fukuta F, et al. (2013). Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer risk. Asian Pac J Cancer Prev, 14, 1-4. https://doi.org/10.7314/APJCP.2013.14.1.1
  43. Toan PV, Sebesvari Z, Blasing M, Rosendahl I, Renaud FG (2013). Pesticide management and their residues in sediments and surface and drinking water in the Mekong Delta, Vietnam. Science of the Total Environment, 452, 28-39.
  44. Tung ND (2010). Cancer incidence in the population of Thua Thien Hue province, Vietnam, 2001-2009. Journal of Science, Hue University, 27, 7.
  45. Tymchuk CN, Barnard RJ, Heber D, Aronson WJ (2001). Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth. J Urol, 166, 1185-9. https://doi.org/10.1016/S0022-5347(05)65943-5
  46. Vietnam National Cancer Hospital. (2008). Vietnam national project on cancer control and prevention, 2008- 2010.http://benhvienk.com/pcut/du-an-quoc-gia-ve-pcut.
  47. Vu Le C, Dao OQ, Khac Tran LN (2010). Mass screening of prostate cancer in Vietnam: Current status and our opinions. Urologic Oncol, 28, 673-6. https://doi.org/10.1016/j.urolonc.2009.12.008
  48. Vuong AD, (2005). Methodology for assessment of risk factors of non-communicable diseases-Stepwise approach. Practical Med, 510, 21-21.
  49. Vuong DA, Velasco-Garrido M, Lai TD, Busse R (2010). Temporal trends of cancer incidence in Vietnam, 1993-2007. Asian Pac J Cancer Prev, 11, 739-45.
  50. Walsh P, (2011). Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study editorial comment. J Urol, 186, 903. https://doi.org/10.1016/j.juro.2011.05.037
  51. Wang YF, Ray AM, Johnson EK, et al (2011). Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: the flint men's health study. Prostate, 71, 225-31. https://doi.org/10.1002/pros.21234
  52. Yilmaz E, Devrim E, Perk H, Kacmaz M (2003). Consumption of aqueous garlic extract leads to significant improvement in patients with benign prostate hyperplasia and prostate cancer. Nutr Res, 23, 199-204. https://doi.org/10.1016/S0271-5317(02)00495-5
  53. Young-McCaughan S (2012). Potential for prostate cancer prevention through physical activity. World J Urol, 30, 167-79. https://doi.org/10.1007/s00345-011-0812-y

Cited by

  1. The AhR Ligand, TCDD, Regulates Androgen Receptor Activity Differently in Androgen-Sensitive versus Castration-Resistant Human Prostate Cancer Cells vol.12, pp.7, 2015, https://doi.org/10.3390/ijerph120707506
  2. Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL vol.16, pp.13, 2015, https://doi.org/10.7314/APJCP.2015.16.13.5261
  3. Conditional PTEN-deficient Mice as a Prostate Cancer Chemoprevention Model vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1827
  4. Developing a model for forecasting Gleason score ≥7 in potential prostate cancer patients to reduce unnecessary prostate biopsies vol.48, pp.4, 2016, https://doi.org/10.1007/s11255-016-1218-y
  5. Dietary Carotenoid Intakes and Prostate Cancer Risk: A Case-Control Study from Vietnam vol.10, pp.1, 2018, https://doi.org/10.3390/nu10010070
  6. Prostate Cancer Risk Reduced by Physical Activity Even Among Men With Prolonged Sitting Time: A Study From Vietnam vol.30, pp.3, 2018, https://doi.org/10.1177/1010539518756980
  7. Epidemiology of prostate cancer in Asian countries vol.25, pp.6, 2018, https://doi.org/10.1111/iju.13593